MA50086A - Vésicules extracellulaires (ev) bactériennes - Google Patents

Vésicules extracellulaires (ev) bactériennes

Info

Publication number
MA50086A
MA50086A MA050086A MA50086A MA50086A MA 50086 A MA50086 A MA 50086A MA 050086 A MA050086 A MA 050086A MA 50086 A MA50086 A MA 50086A MA 50086 A MA50086 A MA 50086A
Authority
MA
Morocco
Prior art keywords
vesicles
bacterial extracellular
extracellular
bacterial
Prior art date
Application number
MA050086A
Other languages
English (en)
Inventor
Baundauna Bose
Christopher J H Davitt
Brian Goodman
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of MA50086A publication Critical patent/MA50086A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA050086A 2017-09-08 2018-09-10 Vésicules extracellulaires (ev) bactériennes MA50086A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762556015P 2017-09-08 2017-09-08
US201862669151P 2018-05-09 2018-05-09

Publications (1)

Publication Number Publication Date
MA50086A true MA50086A (fr) 2020-07-15

Family

ID=63832482

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050086A MA50086A (fr) 2017-09-08 2018-09-10 Vésicules extracellulaires (ev) bactériennes

Country Status (14)

Country Link
US (2) US11524037B2 (fr)
EP (1) EP3678693A1 (fr)
JP (1) JP7369690B2 (fr)
KR (1) KR20200053531A (fr)
CN (1) CN111148531A (fr)
AR (1) AR113011A1 (fr)
AU (1) AU2018330322A1 (fr)
BR (1) BR112020004264A2 (fr)
CA (1) CA3075268A1 (fr)
CO (1) CO2020004233A2 (fr)
MA (1) MA50086A (fr)
MX (1) MX2020002659A (fr)
TW (1) TWI814739B (fr)
WO (1) WO2019051380A1 (fr)

Families Citing this family (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109563470B (zh) * 2016-06-14 2023-04-07 健康生物公司 对退行性脑疾病具有预防或治疗效果的agathobaculum属菌株及其应用
KR102480965B1 (ko) 2016-09-13 2022-12-26 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
KR20200024940A (ko) 2017-07-27 2020-03-09 로커스 아이피 컴퍼니 엘엘씨 의약품, 보충제 및 섭취된 물질의 생체 이용률을 향상시키기 위한 조성물
EP3678693A1 (fr) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Vésicules extracellulaires (ev) bactériennes
JP7402805B2 (ja) * 2018-02-06 2023-12-21 エヴェロ バイオサイエンシズ，インコーポレーテッド ベイロネラ（Ｖｅｉｌｌｏｎｅｌｌａ）の細菌を使用して癌及び免疫障害を処置するための組成物及び方法
KR102122898B1 (ko) * 2018-02-26 2020-06-15 주식회사 엠디헬스케어 블라우티아 속 세균 유래 나노소포 및 이의 용도
WO2019178490A1 (fr) 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions et procédés pour traiter le cancer et l'inflammation utilisant klebsiella oxytoca
WO2019178494A1 (fr) 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions et méthodes de traitement du cancer et de l'inflammation à l'aide de tyzzerella nexilis
WO2019178487A2 (fr) 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions et méthodes de traitement d'une maladie à l'aide de klebsiella quasipneumoniae subsp. similipneumoniae
US11433139B2 (en) 2018-03-16 2022-09-06 Zoetis Services Llc Peptide vaccines against interleukin-31
US12194066B2 (en) 2018-05-30 2025-01-14 University Of Florida Researchfoundation, Incorporated Mechanistic bacterial efector to prevent apoptosis of human beta cells
CN108949699B (zh) * 2018-08-03 2020-09-04 江南大学 一种分泌美洛昔康单克隆抗体的杂交瘤细胞株及其应用
AU2019351019B2 (en) 2018-09-27 2024-09-19 Research Development Foundation Methods and probiotic compositions for the treatment of bone disorders
CN109207425A (zh) * 2018-09-29 2019-01-15 中国医科大学附属口腔医院 牙龈卟啉单胞菌诱导巨噬细胞外泌体rna表达研究方法
JP7240031B2 (ja) * 2018-12-10 2023-03-15 エムディー ヘルスケア インコーポレイテッド ワイセラ属細菌由来のナノ小胞およびその用途
US20220047648A1 (en) * 2019-01-09 2022-02-17 Md Healthcare Inc. Nanovesicles derived from bacteria of genus rhodococcus, and use thereof
US20220090171A1 (en) * 2019-01-09 2022-03-24 Md Healthcare Inc. Nanovesicles derived from bacteria of genus deinococcus, and use thereof
CN109762762A (zh) * 2019-01-11 2019-05-17 江苏大学 一种脂肽的高产菌株及其制备方法和用途
KR102285335B1 (ko) * 2019-02-14 2021-08-04 주식회사 엠디헬스케어 로치아 속 세균 유래 나노소포 및 이의 용도
CN113727722A (zh) * 2019-02-22 2021-11-30 伊夫罗生物科学公司 细菌膜制剂
CN110195028B (zh) * 2019-03-08 2022-03-01 大连理工大学 一种堆肥低温复合发酵菌剂的制备方法及应用
CN113747908B (zh) * 2019-04-17 2025-07-18 生命大地女神有限公司 益生菌的治疗性微泡
WO2020214961A1 (fr) * 2019-04-17 2020-10-22 Codiak Biosciences, Inc. Méthodes de traitement de la tuberculose
CN111991427A (zh) * 2019-05-07 2020-11-27 瑞微（深圳）生物科技有限公司 肠道细菌在制备用于促进TCR γδ+T细胞增殖的药物中的应用
CN110317744B (zh) * 2019-05-08 2021-11-05 安徽农业大学 一种生产蓝紫色素的马赛菌及其生产蓝紫色素的方法
CA3143025A1 (fr) * 2019-06-11 2020-12-17 Evelo Biosciences, Inc. Vesicules extracellulaires microbiennes traitees
BR112021025788A2 (pt) 2019-06-20 2022-03-03 Locus Ip Co Llc Cocultivo de uma mixobactéria e acinetobacter para produção potencializada de emulsan
PH12021553137A1 (en) 2019-07-19 2022-07-25 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
KR20220044315A (ko) * 2019-08-05 2022-04-07 에벨로 바이오사이언시즈, 인크. 프레보텔라 히스티콜라를 사용한 건선 및 아토피성 피부염을 치료하기 위한 조성물 및 방법
CN110577910B (zh) * 2019-09-17 2022-02-01 南京农业大学 一种侧孢短芽孢杆菌、抗菌脂肽及其在农业与食品上的应用
JP7761556B2 (ja) * 2019-09-18 2025-10-28 リサーチ ディベロップメント ファウンデーション 代謝性疾患および障害を治療するための方法およびプロバイオティック組成物
CN110628862A (zh) * 2019-09-24 2019-12-31 哈尔滨工业大学 一种废水梯级能源回收的自聚集颗粒污泥构建方法
CN110982729A (zh) * 2019-10-23 2020-04-10 江苏省中国科学院植物研究所 一种降解木材加工副产物杨树皮纤维素的复合菌剂
CN110804621A (zh) * 2019-10-31 2020-02-18 郑州大学 一种内源性高表达miRNA的大肠杆菌胞外囊泡的制备方法
US20230081756A1 (en) * 2019-12-31 2023-03-16 Xbiome Inc. Compositions comprising bacterial species and methods related thereto
WO2021137494A1 (fr) * 2020-01-02 2021-07-08 삼육대학교산학협력단 Composition pour la prévention ou le traitement du diabète comprenant une souche de butyricimonas sp. en tant que principe actif
WO2021142279A1 (fr) * 2020-01-10 2021-07-15 Evelo Biosciences, Inc. Compositions et procédés de traitement à l'aide de veillonella parvula
US20230121528A1 (en) * 2020-01-13 2023-04-20 Vaximm Ag Salmonella-based dna vaccines in combination with an antibiotic
WO2021146523A1 (fr) * 2020-01-17 2021-07-22 Evelo Biosciences, Inc. Formes posologiques solides à profils de désintégration améliorés
US20240009256A1 (en) * 2020-02-04 2024-01-11 University Of Louisville Research Foundation, Inc. Use of probiotic bacterium-derived extracellular micro- and/or nanoparticles for the treatment of disease
CN111052997B (zh) * 2020-02-25 2022-07-01 青岛农业大学 一种提高草莓连作障碍抗性生物刺激素的制备及应用方法
US11253534B2 (en) 2020-03-23 2022-02-22 Sabine Hazan Method of preventing COVID-19 infection
US11744866B2 (en) 2020-03-18 2023-09-05 Sabine Hazan Methods of preventing and treating COVID-19 infection with probiotics
US11278520B2 (en) 2020-03-31 2022-03-22 Sabine Hazan Method of preventing COVID-19 infection
WO2021195577A2 (fr) * 2020-03-26 2021-09-30 Persephone Biosciences, Inc. Compositions pour moduler des populations de microflore intestinale, améliorer l'efficacité des médicaments et traiter des infections virales, et procédés de fabrication et d'utilisation de celles-ci
CA3174352A1 (fr) * 2020-04-03 2021-10-07 Sofia FORSSTEN Compositions pour la sante metabolique
EP4133107A1 (fr) * 2020-04-06 2023-02-15 Yeda Research and Development Co. Ltd Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
KR102273232B1 (ko) * 2020-05-08 2021-07-06 코스맥스 주식회사 마이크로코커스 리래 균주 및 그의 피부 상태 개선 용도
KR102273234B1 (ko) * 2020-05-08 2021-07-06 코스맥스 주식회사 코쿠리아 바리안스 균주 및 그의 피부 상태 개선 용도
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
GB202007452D0 (en) 2020-05-19 2020-07-01 Microbiotica Ltd Threrapeutic bacterial composition
WO2021242056A1 (fr) * 2020-05-28 2021-12-02 주식회사 바이오뱅크힐링 Souche de l'espèce bifidobacterium et vésicule extracellulaire dérivée de cette dernière, et leurs utilisations anti-inflammatoires et antibactériennes
JP2023530888A (ja) * 2020-06-11 2023-07-20 エヴェロ バイオサイエンシズ，インコーポレーテッド フルニエレラ・マシリエンシス（Ｆｏｕｒｎｉｅｒｅｌｌａ ｍａｓｓｉｌｉｅｎｓｉｓ）を用いて疾患及び障害を治療するための組成物及び方法
WO2021252861A1 (fr) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions et méthodes de traitement de maladies et de troubles à l'aide de mégasphaera sp.
TW202214276A (zh) * 2020-06-11 2022-04-16 美商艾弗洛生物科技股份有限公司 使用ｈａｒｒｙｆｌｉｎｔｉａ ａｃｅｔｉｓｐｏｒａ治療疾病和障礙之組成物及方法
BR112022025128A2 (pt) * 2020-06-11 2023-01-17 Evelo Biosciences Inc Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae
CA3181432A1 (fr) * 2020-06-16 2021-12-23 Yoon-Keun Kim Composition pour prevenir ou traiter des troubles neurologiques ou mentaux comprenant des vesicules issues de lactobacillus paracasei
AU2021296649A1 (en) * 2020-06-22 2023-02-09 Sl Bigen, Inc. Method and composition for enhancing cancer treatment efficacy of bacteria extracellular vesicles
KR102469138B1 (ko) * 2020-07-07 2022-11-22 주식회사 엘제이바이오 파라클로스트리디움 벤조에리티쿰 ｋｓ３ 균주를 포함하는 가축 사체 분해 촉진용 미생물 제제
CN111743922B (zh) * 2020-07-14 2022-03-29 华熙生物科技股份有限公司 一种提高益生菌在鼻腔中的定植和活性的组合物及在鼻腔护理中的应用
EP4185307A1 (fr) * 2020-07-21 2023-05-31 Evelo Biosciences, Inc. Souche de veillonella parvula en tant que thérapie orale pour des maladies neuro-inflammatoires
US20230293599A1 (en) * 2020-08-03 2023-09-21 Universiteit Gent Bacterial compositions with anti-inflammatory activity
CN111876359A (zh) * 2020-08-04 2020-11-03 榆林沙漠王生物科技有限公司 一种用于蔬菜残体资源化处理的复配菌剂及其制备方法及应用
EP4201415A4 (fr) * 2020-08-14 2024-08-21 Kobiolabs, Inc. Souche de faecalibacterium prausnitzii et ses utilisations
CN112094820B (zh) * 2020-09-17 2021-12-07 扬州大学 霍氏肠杆菌噬菌体yzu.p.a-5及其应用
MX2023003089A (es) * 2020-09-18 2023-05-09 Evelo Biosciences Inc Formas farmaceuticas solidas de bacterias.
CN112094328A (zh) * 2020-09-21 2020-12-18 华南农业大学 一种空肠弯曲杆菌外膜囊泡的提取及纯化方法
TW202227111A (zh) * 2020-09-21 2022-07-16 美商艾弗洛生物科技股份有限公司 具有改善的崩散譜之固體劑型
CN112094778B (zh) * 2020-09-24 2022-06-24 千禾味业食品股份有限公司 一种魏斯氏菌las1、制备方法及其应用
TW202233213A (zh) * 2020-10-29 2022-09-01 美商艾弗洛生物科技股份有限公司 包含螺旋藻組分之組成物
CN114438235A (zh) * 2020-11-04 2022-05-06 深圳市南山区疾病预防控制中心 一种同时检测嗜低温弓形杆菌及斯氏弓形杆菌的引物探针组件、试剂盒及其应用
US20240033303A1 (en) * 2020-12-08 2024-02-01 Md Healthcare Inc. Composition for preventing or treating neurological diseases or psychiatric diseases comprising vesicles derived from sphingomonas bacteria
KR102269962B1 (ko) 2020-12-11 2021-06-28 주식회사 바이오뱅크힐링 유박테리움 리모숨 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
FR3118060B1 (fr) * 2020-12-18 2025-03-14 Univ Bourgogne Utilisation anti-biofilm de vesicules membranaires extracellulaires
WO2022139530A1 (fr) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 Composition destinée à réduire, prévenir ou traiter des maladies auto-immunes comprenant des vésicules extracellulaires dérivées de lactobacillus sakei en tant que principe actif
WO2022139532A1 (fr) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 Composition pour améliorer, prévenir ou traiter une stéatose hépatique, comprenant une vésicule extracellulaire dérivée de weissella hellenica en tant que principe actif
WO2022139531A1 (fr) * 2020-12-23 2022-06-30 주식회사 리스큐어바이오사이언시스 Composition pour améliorer, prévenir ou traiter une stéatose hépatique comprenant des vésicules extracellulaires dérivées de leuconostoc citreum en tant que principe actif
KR102651196B1 (ko) * 2020-12-28 2024-03-27 주식회사 엠디헬스케어 마이크로코커스 루테우스 유래 세포외 소포를 포함하는 안질환 예방 또는 치료용 조성물
WO2022145902A1 (fr) * 2020-12-28 2022-07-07 주식회사 리스큐어바이오사이언시스 Composition pharmaceutique destinée à la prévention ou au traitement du cancer, comprenant des nanovésicules dérivées d'une souche de lactobacillus sakei en tant qu'ingrédient actif
JP2024500997A (ja) * 2020-12-28 2024-01-10 エムディー ヘルスケア インコーポレイテッド マイクロコッカス・ルテウス由来細胞外小胞を含む好中球性肺疾患の予防または治療用組成物
WO2022145901A1 (fr) * 2020-12-28 2022-07-07 주식회사 리스큐어바이오사이언시스 Composition pharmaceutique pour la prévention ou le traitement du cancer comprenant des nanovésicules dérivées d'une souche de lactobacillus fermentum en tant que principe actif
WO2022145900A1 (fr) * 2020-12-28 2022-07-07 주식회사 리스큐어바이오사이언시스 Composition pharmaceutique pour la prévention ou le traitement du cancer, comprenant en tant que principe actif des nanovésicules issues d'une souche de weissella cibaria
JP2024501034A (ja) * 2020-12-28 2024-01-10 エムディー ヘルスケア インコーポレイテッド マイクロコッカス・ルテウス由来細胞外小胞を含む神経発達疾患、神経疾患、または精神疾患の予防または治療用組成物
WO2022154149A1 (fr) * 2021-01-14 2022-07-21 (주)엑솔런스 Composition vaccinale utilisant une vésicule extracellulaire
EP4285916A4 (fr) 2021-02-01 2024-12-18 MD Healthcare Inc. Composition comprenant des vésicules dérivées de lactobacillus paracasei pour prévenir, traiter ou soulager des maladies infectieuses virales ou des maladies respiratoires
WO2022177412A1 (fr) * 2021-02-22 2022-08-25 주식회사 리스큐어바이오사이언시스 Composition pharmaceutique pour la prévention ou le traitement du cancer comprenant en tant que principe actif des nanovésicules issues d'une souche de weissella cibaria
US20240148797A1 (en) * 2021-02-26 2024-05-09 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
US20240156879A1 (en) * 2021-03-08 2024-05-16 Juntendo Educational Foundation Composition and ameliorating agent having inflammation reducing effect
IL305830A (en) * 2021-03-12 2023-11-01 Marvelbiome Inc Methods and uses of microbiome compositions, components or metabolites for the treatment of eye disorders
US20240180833A1 (en) * 2021-04-02 2024-06-06 Md Healthcare Inc. Nanovesicles derived from bacteria of the genus paracoccus and use thereof
CN113186172A (zh) * 2021-04-06 2021-07-30 天津农学院 共表达Apoptin与MEL基因的重组腺病毒及构建方法和应用
WO2022221183A1 (fr) * 2021-04-12 2022-10-20 Evelo Biosciences, Inc. Préparations de vésicules extracellulaires de fournierella
CN113025534B (zh) * 2021-04-26 2022-05-27 佛山市南海东方澳龙制药有限公司 一株具有较强抑菌作用的新种芽孢杆菌x901株及其应用
CN115305211A (zh) * 2021-05-07 2022-11-08 葡萄王生技股份有限公司 益生菌胞外泌体及其用途
US12599625B2 (en) 2021-05-13 2026-04-14 Penland Foundation Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics
CN113186134B (zh) * 2021-05-17 2022-11-01 中国科学院水生生物研究所 一种蓝藻气囊提取方法及其应用
CN113122483A (zh) * 2021-05-31 2021-07-16 哈尔滨工业大学 一种玉米秸秆好氧堆肥的快速产热菌剂及其应用
KR102661178B1 (ko) * 2021-06-03 2024-04-29 주식회사 엠디헬스케어 락토바실러스 파라카세이 유래 세포외소포를 포함하는 안질환 예방 또는 치료용 조성물
EP4119151A4 (fr) * 2021-06-03 2023-10-25 MD Healthcare Inc. Composition pour la prévention ou le traitement de maladies oculaires comprenant des vésicules extracellulaires issues de lactobacillus paracasei
WO2022255795A1 (fr) * 2021-06-03 2022-12-08 주식회사 엠디헬스케어 Vésicules extracellulaires issues de bactéries lactobacilles et leur utilisation
US20240252560A1 (en) * 2021-06-03 2024-08-01 Md Healthcare Inc. Lactobacillus rhamnosus-derived vesicle and uses thereof
JP2024520165A (ja) * 2021-06-07 2024-05-21 エムディー ヘルスケア インコーポレイテッド ロイコノストック細菌由来小胞を含む炎症疾患あるいはがんの予防または治療用組成物
KR102850200B1 (ko) * 2021-06-18 2025-08-27 경북대학교 산학협력단 핵산 백신 제조 및 유전자 전달을 위한 세균 유래 세포밖 소포체의 용도
WO2023287726A1 (fr) 2021-07-12 2023-01-19 Penland Foundation Traitement du cancer à l'aide de toxine botulique et d'oxyde nitreux
EP4376880A4 (fr) * 2021-07-28 2025-06-18 The Texas A&M University System Compositions de vaccin comprenant des souches de brucella et leurs procédés
CN114128891A (zh) * 2021-07-28 2022-03-04 黑龙江飞鹤乳业有限公司 一种促进婴儿肠道发育的菌株及其应用
KR102390755B1 (ko) * 2021-09-06 2022-04-28 한국식품연구원 웨이셀라 파라메센테로이데스 WiKim0137 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
KR102390775B1 (ko) * 2021-09-06 2022-05-04 한국식품연구원 류코노스톡 슈도메센테로이데스 WiKim0138 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
KR102558084B1 (ko) * 2021-09-14 2023-07-21 코스맥스 주식회사 두피 마이크로바이옴 콤플렉스 및 그의 모발 또는 두피 상태 개선 용도
CN113999789B (zh) * 2021-09-30 2022-11-15 沈阳农业大学 一株产鲜味肽的嗜盐四联球菌及应用
WO2023062422A1 (fr) * 2021-10-11 2023-04-20 Vastu Vihar Biotech Private Limited Composition anti-inflammatoire et son procédé d'obtention
KR102411241B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 코리네박테리움 상귀니스의 피부 상태 개선 용도
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
KR102881730B1 (ko) * 2021-10-20 2025-11-06 주식회사 고바이오랩 항암 활성을 갖는 신규 박테리아 균주 및 이를 이용한 암의 완화, 예방 또는 치료용 조성물
KR102739746B1 (ko) * 2021-10-25 2024-12-10 인하대학교 산학협력단 바르토넬라 헨셀라이 유래 세포외 소포체를 이용한 바르토넬라 감염증 진단 방법
WO2023075458A1 (fr) * 2021-10-27 2023-05-04 주식회사 바이오뱅크힐링 Nouvelle souche bactérienne, vésicules dérivées de celle-ci, et utilisation anti-inflammatoire et anti-bactérienne associées
CN114085792B (zh) * 2021-11-17 2023-03-24 哈尔滨医科大学 一种用于防治结肠癌的副干酪乳杆菌及其应用
EP4437083A2 (fr) * 2021-11-22 2024-10-02 International N&H Denmark ApS Compositions pour santé métabolique
CA3238764A1 (fr) 2021-11-23 2023-06-01 Siddharth Patel Composition lipidique derivee de bacteries et son utilisation
WO2023114300A1 (fr) * 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Préparations de vésicules extracellulaires de bactéries fournierella massiliensis
WO2023114293A1 (fr) * 2021-12-14 2023-06-22 Evelo Biosciences, Inc. Dosages de vésicules extracellulaires
EP4448111A4 (fr) * 2021-12-15 2026-03-18 Univ Texas Procédés et compositions pour modifier un microbiome tumoral
CN114369673B (zh) * 2022-01-06 2023-07-14 同济大学 结直肠腺瘤生物标志物、试剂盒及生物标志物的筛选方法
EP4467148A4 (fr) * 2022-01-20 2025-04-23 Korea Institute of Science and Technology Composition pour prévention, amélioration ou traitement d'une stéatose hépatique non alcoolique, comprenant des vésicules extracellulaires dérivées de roseburia spp. ou de bifidobacterium spp
CN114807032B (zh) * 2022-05-20 2023-09-12 南京大学 地塞米松诱导中性粒细胞产生的细胞外囊泡在制备治疗消炎药物中的应用
KR102509869B1 (ko) * 2022-07-14 2023-03-14 주식회사 엔테로바이옴 아커만시아를 포함하는 탈모 예방 또는 치료용 약학적 조성물
KR102626400B1 (ko) * 2022-08-31 2024-01-19 주식회사 바이오뱅크힐링 도레아 론기카테나 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102620189B1 (ko) * 2022-08-31 2024-01-04 주식회사 바이오뱅크힐링 블라우티아 브룩킹시 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
KR102620190B1 (ko) * 2022-08-31 2024-01-04 주식회사 바이오뱅크힐링 아가토박터 렉탈리스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2024049207A1 (fr) * 2022-08-31 2024-03-07 주식회사 바이오뱅크힐링 Nouvelle souche et vésicules qui en sont issues, et leurs utilisations anti-inflammatoires et antibactériennes
CN115590890B (zh) * 2022-10-19 2026-02-17 中南大学湘雅医院 一种双歧杆菌及其胞外囊泡在制备对抗高脂饮食导致的疾病的制剂中的应用
CN116004440B (zh) * 2022-10-25 2025-06-13 深圳未知君生物科技有限公司 一株粘膜粘液乳杆菌及其在制备治疗癌症的药物中的应用
CN115820840A (zh) * 2022-11-23 2023-03-21 武汉轻工大学 一种副猪嗜血杆菌感染后引起仔猪免疫抑制的分子标记物
CN116509900B (zh) * 2022-12-01 2023-11-10 佛山科学技术学院 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用
KR20240114298A (ko) * 2023-01-12 2024-07-23 에스엔제이 파마 인크 감염 저항성 장내 균주 및 그 용도
CN116656583B (zh) * 2023-01-13 2024-06-18 南昌大学 靶向肿瘤的幽门螺杆菌突变株及抗胃癌外膜囊泡组合物
CN118496306A (zh) * 2023-02-14 2024-08-16 南京农业大学 一种利用重组枯草芽孢杆菌制备抗应激肽lgspdvivir的方法及应用
KR102945111B1 (ko) * 2023-02-21 2026-04-03 주식회사 엠디헬스케어 류코노스톡 속 세균 유래 소포를 포함하는 대사질환, 간질환, 또는 근육질환 예방 또는 치료용 조성물
CN116622548B (zh) * 2023-03-31 2024-02-09 吉林农业大学 一株能够预防和或治疗牙周炎的嵴链球菌及其应用
CN116355811B (zh) * 2023-04-26 2025-03-18 南京农业大学 一种食淀粉乳杆菌及其在改善胆汁淤积性肝病中的应用
CN116606766B (zh) * 2023-04-26 2025-02-25 南京农业大学 一种食淀粉乳杆菌胞外囊泡的制备方法及其应用
CN116747245B (zh) * 2023-06-14 2024-06-21 辽宁越秀辉山营养科技有限公司 动物双歧杆菌乳亚种bx-245在抑菌和/或生产功能活性物质中的应用
CN117180317B (zh) * 2023-11-02 2024-01-26 深圳市第二人民医院(深圳市转化医学研究院) 詹氏乳杆菌来源纳米囊泡在制备防治卵巢早衰治疗药物中的应用
CN117402794B (zh) * 2023-12-12 2024-02-27 四川厌氧生物科技有限责任公司 一种加氏乳杆菌及其应用
KR20250104680A (ko) * 2023-12-29 2025-07-08 한국생명공학연구원 잔티노박테리움 속 균주 또는 비올라세인을 포함하는 발모 촉진 또는 탈모 예방 또는 치료용 조성물
WO2025183435A1 (fr) * 2024-02-26 2025-09-04 주식회사 건강약품 Microvésicules dérivées d'infantis, sous-espèce de bifidobacterium longum, et leurs utilisations
WO2025198344A1 (fr) * 2024-03-20 2025-09-25 이화여자대학교 산학협력단 Nouvelles bactéries lactiques et leur utilisation
CN118006515B (zh) * 2024-04-08 2024-06-18 中国农业大学 一株乳酸乳球菌及其在制备治疗牛乳腺炎的药物中的应用
WO2025244670A1 (fr) * 2024-05-23 2025-11-27 Candel Therapeutics, Inc. Méthodes de traitement du cancer du poumon
WO2026021930A2 (fr) 2024-07-24 2026-01-29 Henriques Normark Birgitta Immunisation contre le streptocoque du groupe a (gas)
CN118845855A (zh) * 2024-08-19 2024-10-29 广州医科大学附属第二医院 詹氏乳杆菌来源纳米囊泡在制备预防和/或治疗鼻息肉药物中的应用
CN119530061B (zh) * 2024-11-14 2025-07-25 广东医科大学附属医院 一种肠道微生物组合在制备治疗sle药物中的应用
CN119144523A (zh) * 2024-11-19 2024-12-17 哈尔滨医科大学 一株铅黄肠球菌及其外泌体的应用
CN119752719B (zh) * 2024-12-30 2025-12-16 中国疾病预防控制中心传染病预防控制所 一种纤细副梭菌Pt517及其在制备抗炎或抑菌产品中的应用
CN119932075A (zh) * 2025-01-25 2025-05-06 四川大学 一种携带外源蛋白的重组单增李斯特菌膜囊泡及其制备方法和应用
CN119955687B (zh) * 2025-04-10 2025-07-01 西南民族大学 一株具有益生活性的融合魏斯氏菌dy12及其应用
CN120442727A (zh) * 2025-05-07 2025-08-08 湖南湘农动物药业有限公司 富含有机铜的罗伊氏乳杆菌hadig-lr003后生元的制备及其应用
CN120866469A (zh) * 2025-09-29 2025-10-31 上海交通大学医学院附属仁济医院 一种肠道细菌新生外囊泡的分离检测方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US5322784A (en) 1991-06-05 1994-06-21 The Board Of Trustees Of The University Of Illinois, Urbana-Champaign, Illinois Method and materials for introducing DNA into Prevotella ruminicola
HUP0204546A3 (en) 2000-03-01 2003-10-28 Nestle Sa Carbohydrate formulation for enhancement of immune response
US6812023B1 (en) 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
ES2519440T3 (es) * 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
EP1618891A1 (fr) 2003-03-31 2006-01-25 Kirin Beer Kabushiki Kaisha Methode d'induction de differenciation et de proliferation de cellules t regulatrices par un anticorps anti-cd52 et composition medicinale associee
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
US20050100559A1 (en) 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
JP5173194B2 (ja) 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
WO2008147816A2 (fr) 2007-05-22 2008-12-04 Cornell Research Foundation, Inc. Compositions et procédés d'affichage de protéines sur la surface de bactéries et leurs vésicules dérivées et utilisations de celles-ci
WO2011027971A2 (fr) 2009-09-01 2011-03-10 주식회사이언메딕스 Vésicules extracellulaires dérivées de la flore intestinale, et procédé de recherche d'un modèle de maladie, d'un vaccin et d'un médicament candidat, et de diagnostic utilisant ce dernier
WO2011027956A2 (fr) 2009-09-04 2011-03-10 주식회사이언메딕스 Vésicules extracellulaires issues de bactéries à gram positif, et modèle de maladie utilisant celles-ci
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
EP2486940B1 (fr) 2009-10-08 2017-10-04 Aeon Medix Inc. Composition comprenant des vésicules de membranes extracellulaires issues de l'air intérieur, et utilisation de celle-ci
WO2011053653A2 (fr) 2009-10-30 2011-05-05 Mayo Foundation For Medical Education And Research Préparations à base de prevotella histicola et traitement d'états auto-immuns
KR101629525B1 (ko) 2010-01-11 2016-06-13 이화여자대학교 산학협력단 발효식품에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
JP5635690B2 (ja) 2010-07-01 2014-12-03 ポステック アカデミー‐インダストリー ファウンデーション 細菌由来マイクロベシクルを用いた癌治療及び癌診断方法
WO2012093754A1 (fr) 2011-01-04 2012-07-12 포항공과대학교 산학협력단 Composition comprenant des vésicules extracellulaires provenant de l'intérieur d'un corps de mammifère et utilisation de celle-ci
WO2012093755A1 (fr) 2011-01-04 2012-07-12 포항공과대학교 산학협력단 Composition comprenant des vésicules extracellulaires provenant d'une nourriture fermentée et utilisation de celle-ci
WO2014152484A1 (fr) * 2013-03-14 2014-09-25 Regents Of The University Of Minnesota Microbiote fécal lyophilisé à utiliser dans la transplantation microbienne fécale
US9968638B2 (en) 2011-03-09 2018-05-15 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
KR101421779B1 (ko) 2011-04-08 2014-07-28 주식회사이언메딕스 아시네토박터 속 세균유래 세포밖 소포체 및 이의 용도
TWI573590B (zh) 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
MX363923B (es) 2011-12-28 2019-04-08 Galectin Therapeutics Inc Composicion de farmaco de carbohidrato novedoso para el tratamiento de enfermedades humanas.
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
JP2016509003A (ja) 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
JP2016507543A (ja) 2013-02-07 2016-03-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 小胞を含む医薬組成物
TR201815566T4 (tr) 2013-06-03 2018-11-21 Proprev Ab Prevotella'dan en az bir bakteri suşu kullanarak obezite, metabolik sendrom, tip 2 diyabet, kardiyovasküler hastalıklar, demans, alzheimer hastalığı ve enflamatuvar bağırsak hastalığının tedavisi.
KR101740893B1 (ko) 2014-05-20 2017-06-13 주식회사 엠디헬스케어 Ａｋｋｅｒｍａｎｓｉａ ｍｕｃｉｎｉｐｈｉｌａ 균에서 유래하는 세포밖 소포를 유효성분으로 함유하는 대사질환의 치료 또는 예방용 조성물
AU2015326407C1 (en) 2014-10-03 2021-06-24 Engeneic Molecular Delivery Pty Ltd Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016090183A1 (fr) 2014-12-03 2016-06-09 Capricor Therapeutics, Inc. Procédés de production de formulations d'exosomes stables
KR101726488B1 (ko) 2015-02-23 2017-04-13 이화여자대학교 산학협력단 바실러스 속 세균 유래 세포밖 소포체를 포함하는 임신관련 질환 치료용 조성물
KR20160107632A (ko) 2015-03-04 2016-09-19 포항공과대학교 산학협력단 뉴클레아제가 처리된 세균 유래 세포밖 소포체를 이용한 세균 동정 방법
WO2016144139A2 (fr) 2015-03-11 2016-09-15 주식회사 엠디헬스케어 Composition pour prévenir ou traiter des maladies inflammatoires, comprenant des vésicules extracellulaires dérivées de bactéries d'acide lactique comme principes actifs
CA2979086A1 (fr) 2015-03-12 2016-09-15 The University Of British Columbia Compositions bacteriennes et leurs procedes d'utilisation
KR102394638B1 (ko) 2015-09-30 2022-05-09 (주)아모레퍼시픽 유산균 유래의 세포외 소낭을 포함하는 탈모 방지 또는 육모 촉진용 조성물
WO2017087811A1 (fr) 2015-11-20 2017-05-26 Massachusetts Institute Of Technology Vésicules membranaires externes de bacteroides modifiés
WO2017123025A1 (fr) 2016-01-15 2017-07-20 주식회사 엠디헬스케어 Régulateur pour troubles de la fonction immunitaire des voies respiratoires, utilisant des vésicules extracellulaires d'origine bactérienne
US10722543B2 (en) 2016-01-28 2020-07-28 Oxyrase, Inc. Methods for inhibiting tumor growth using anaerobe microorganisms
ME03487B (fr) 2016-03-04 2020-01-20 4D Pharma Plc Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
EP3678693A1 (fr) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Vésicules extracellulaires (ev) bactériennes
EP3679057A1 (fr) 2017-09-08 2020-07-15 Evelo Biosciences, Inc. Vésicules extracellulaires provenant de prevotella

Also Published As

Publication number Publication date
CO2020004233A2 (es) 2020-04-24
TW201919673A (zh) 2019-06-01
CN111148531A (zh) 2020-05-12
US20200254028A1 (en) 2020-08-13
MX2020002659A (es) 2020-09-09
US12109243B2 (en) 2024-10-08
AR113011A1 (es) 2020-01-15
JP7369690B2 (ja) 2023-10-26
WO2019051380A1 (fr) 2019-03-14
KR20200053531A (ko) 2020-05-18
US11524037B2 (en) 2022-12-13
CA3075268A1 (fr) 2019-03-14
AU2018330322A1 (en) 2020-03-19
JP2020533290A (ja) 2020-11-19
EP3678693A1 (fr) 2020-07-15
US20230210913A1 (en) 2023-07-06
BR112020004264A2 (pt) 2020-10-06
TWI814739B (zh) 2023-09-11

Similar Documents

Publication Publication Date Title
MA50086A (fr) Vésicules extracellulaires (ev) bactériennes
IL277344A (en) Extracellular vesicles containing agonist-STING
MA50087A (fr) Vésicules extracellulaires provenant de prevotella
EP3618485A4 (fr) Système de communication
EP3565294A4 (fr) Système de communication
EP3562243A4 (fr) Système de communication
IL274124A (en) Protein engineered extracellular vesicles
DK3145949T3 (da) Lentivirale vektorer
HRP20180501T1 (hr) Pripravci koje sadrže bakterijske sojeve
EP3639451C0 (fr) Système de communication
DK3013070T3 (da) Høresystem
GEAP202114450A (en) Anti-tigit antibodies
HUE057917T2 (hu) Immunmodulátor szerek
BR112017000446A2 (pt) arranjos de estação de acionamento
BR112017001200A2 (pt) “curativo laminado de espuma”
DK3006079T3 (da) Høresystem
DK3385377T3 (da) Bakteriemannanaser
SG11202003499YA (en) Immunomodulatory composition comprising lactobacillus-derived extracellular vesicles
EP3238468A4 (fr) Services de localisation
HUE050300T2 (hu) Kétcisztronos bakteriális expressziós rendszer
EP3605867A4 (fr) Système de communication
EP3179740A4 (fr) Excitateur
EP3562112A4 (fr) Système de communication
GB2555997B (en) Downhole acoustic source localization
FR3040689B1 (fr) Drone aeroterrestre de livraison